Summary of Study ST000288
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000230. The data can be accessed directly via it's Project DOI: 10.21228/M8XG6C This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST000288 |
Study Title | Metabolomic profiling of AML Cell Lines |
Study Type | In vitro study |
Study Summary | In vitro study with AML cell lines that are treated with different concentrations of cytarabine (nucleoside analog). 8 AML cell lines were incubated for 24hr with 0uM, 1uM and 10uM ara-C. After 24hr the cells were washed and pellets were stored in -80°C for genomic and metabolomic analysis. |
Institute | University of Florida |
Department | SECIM |
Last Name | Bhise |
First Name | Neha |
Address | - |
nbhise@cop.ufl.edu | |
Phone | 352-294-5745 |
Submit Date | 2015-02-15 |
Num Groups | 3 |
Total Subjects | 24 |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2016-12-22 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000230 |
Project DOI: | doi: 10.21228/M8XG6C |
Project Title: | Identification of Factors Influencing Nucleoside Analog Sensitivity |
Project Summary: | The metabolomic profiles of cytogenetically different AML cell lines are associated with variability in response of these cell lines to nucleoside analogs. The treatment with nucleoside analog (cytarabine) would result in changes in the metabolomic profile of the AML cell lines. |
Institute: | University of Florida |
Department: | Pharmacotherapy and Translational Research |
Last Name: | Lamba |
First Name: | Jatinder |
Address: | - |
Email: | jlamba@cop.ufl.edu |
Phone: | 352-273-6425 |
Subject:
Subject ID: | SU000308 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Subject Comments: | Lamba_Subjects_20150210.docx |
Species Group: | Human |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Cytarabin Treatment (uM) |
---|---|---|
SA013134 | Lamba_HL60_1 | 0 |
SA013135 | Lamba_KG1_1 | 0 |
SA013136 | Lamba_ME1_1 | 0 |
SA013137 | Lamba_THP1_1 | 0 |
SA013138 | Lamba_MOLM16_1 | 0 |
SA013139 | Lamba_AML193_1 | 0 |
SA013140 | Lamba_MV-411_1 | 0 |
SA013141 | Lamba_Kasumi1_1 | 0 |
SA013142 | Lamba_KG1_2 | 1 |
SA013143 | Lamba_MOLM16_2 | 1 |
SA013144 | Lamba_ME1_2 | 1 |
SA013145 | Lamba_HL60_2 | 1 |
SA013146 | Lamba_Kasumi1_2 | 1 |
SA013147 | Lamba_MV-411_2 | 1 |
SA013148 | Lamba_THP1_2 | 1 |
SA013149 | Lamba_AML193_2 | 1 |
SA013150 | Lamba_ME1_3 | 10 |
SA013151 | Lamba_Kasumi1_3 | 10 |
SA013152 | Lamba_HL60_3 | 10 |
SA013153 | Lamba_THP1_3 | 10 |
SA013154 | Lamba_KG1_3 | 10 |
SA013155 | Lamba_MV-411_3 | 10 |
SA013156 | Lamba_AML193_3 | 10 |
SA013157 | Lamba_MOLM16_3 | 10 |
Showing results 1 to 24 of 24 |
Collection:
Collection ID: | CO000302 |
Collection Summary: | See protocol file |
Collection Protocol Filename: | Lamba_Collection_20150210.docx |
Sample Type: | Cells |
Treatment:
Treatment ID: | TR000322 |
Treatment Summary: | See treatment file |
Treatment Protocol Filename: | Lamba_Treatment_20150210.docx |
Sample Preparation:
Sampleprep ID: | SP000316 |
Sampleprep Summary: | See files |
Sampleprep Protocol Filename: | cell_pellet_preparation.pdf, Appendix C_Protein_DNA_quant.pdf |
Combined analysis:
Analysis ID | AN000458 | AN000459 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | Reversed phase | Reversed phase |
Chromatography system | Thermo Scientific-Dionex Ultimate 3000 | Thermo Scientific-Dionex Ultimate 3000 |
Column | ACE Excel 2 C18-PFP (100 x 2.1mm, 2um) | ACE Excel 2 C18-PFP (100 x 2.1mm, 2um) |
MS Type | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap |
MS instrument name | Thermo Q Exactive Orbitrap | Thermo Q Exactive Orbitrap |
Ion Mode | POSITIVE | NEGATIVE |
Units | Peak area | peak area |
Chromatography:
Chromatography ID: | CH000327 |
Methods Filename: | Metabolomics_LCMSProtocol.pdf |
Instrument Name: | Thermo Scientific-Dionex Ultimate 3000 |
Column Name: | ACE Excel 2 C18-PFP (100 x 2.1mm, 2um) |
Flow Rate: | 0.350mL/min-0.600mL/min |
Internal Standard: | Appendix A - Internal Standard Prep GLCMS.pdf |
Solvent A: | 100% water; 0.1% formic acid |
Solvent B: | 100% acetonitrile |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS000398 |
Analysis ID: | AN000458 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
Ion Mode: | POSITIVE |
Analysis Protocol File: | ST286_Metabolomics_LCMSProtocol.pdf |
MS ID: | MS000399 |
Analysis ID: | AN000459 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
Ion Mode: | NEGATIVE |
Analysis Protocol File: | ST286_Metabolomics_LCMSProtocol.pdf |